Previous studies have demonstrated that tissue factor pathway inhibitor-2 (TFPI-2) is associated with fibrosarcoma [188] and that downregulation of TFPI-2 is associated with tumor growth/metastasis [189]. This evidence concerns the gene TFPI2 and neoplasm.